Mantle cell lymphoma of the iris treated by ibrutinib

被引：0
|
作者：
De Gauzy, T. Sales [1 ]
Oberic, L. [2 ]
Fournie, P. [1 ]
Soler, V. [1 ]
机构：
[1] CHU Toulouse, Ophthalmol Dept, Hop Pierre Paul Riquet, Allee Jean Dausset, F-31300 Toulouse, France
[2] IUCT Oncopole, Hematolgy Dept, Toulouse, France
来源：
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2018年 / 41卷 / 10期
关键词：
DIAGNOSIS;
D O I：
10.1016/j.jfo.2018.07.003
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E501 / E502
页数：2
相关论文
共 50 条
  • [21] Molecular Pathways Associated with Ibrutinib Resistance in Mantle Cell Lymphoma
    Zhang, Liang
    Nomie, Krystle
    Zhang, Shaojun
    Liu, Yang
    Guo, Hui
    Huang, Shengjian
    Wang, Jeffrey
    Lopez, Elyse
    Zhang, Hui
    Lorence, Elizabeth A.
    Merolle, Maria
    Balaji, Swathi
    Ahmed, Makhdum
    Jiang, Changying
    Wang, Linghua
    Wang, Michael
    BLOOD, 2017, 130
  • [22] Pirtobrutinib Overcomes Ibrutinib and Venetoclax Resistance in Mantle Cell Lymphoma
    Liu, Yang
    Jiang, Changying
    Yan, Fangfang
    McIntos, Joseph
    Jordan, Alexa A.
    Li, Yijing
    Che, Yuxuan
    Cai, Qingsong
    Wang, Wei
    Nie, Lei
    Wang, Michael
    BLOOD, 2021, 138
  • [23] Ibrutinib in Mantle Cell Lymphoma Patients: Analysis of the Czech Lymphoma Study Group
    Obr, Ales
    Klener, Pavel, Jr.
    Janikova, Andrea
    Mocikova, Heidi
    Belada, David
    Salek, David
    Jirkuvova, Andrea
    Papajik, Tomas
    Trneny, Marek
    BLOOD, 2021, 138
  • [24] Ibrutinib in refractory mantle cell lymphoma or relapsed data update
    Paillassa, Jerome
    HEMATOLOGIE, 2015, 21 (05): : 257 - 259
  • [25] Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma
    Tam, Constantine S.
    Anderson, Mary Ann
    Pott, Christiane
    Agarwal, Rishu
    Handunnetti, Sasanka
    Hicks, Rodney J.
    Burbury, Kate
    Turner, Gillian
    Di Iulio, Juliana
    Bressel, Mathias
    Westerman, David
    Lade, Stephen
    Dreyling, Martin
    Dawson, Sarah-Jane
    Dawson, Mark A.
    Seymour, John F.
    Roberts, Andrew W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (13): : 1211 - 1223
  • [26] Real-World Outcomes for Patients Treated with Ibrutinib for Relapsed/Refractory Mantle Cell Lymphoma in Denmark
    Trab, Trine
    Chanchiri, Iman
    Al-Mashhadi, Ahmed
    Berggreen, Emma
    Rasch, Stine
    Johansen, Mette
    Husby, Simon
    Clausen, Michael Roost
    Larsen, Thomas Stauffer
    Desseau-Arp, Andriette C.
    Christensen, Jacob Haaber
    Pedersen, Robert Schou
    Frederiksen, Mikael
    Brown, Peter de Nully
    El-Galaly, Tarec Christoffer
    Gronbaek, Kirsten
    BLOOD, 2024, 144 : 6325 - 6326
  • [27] CD52 and OXPHOS-potential targets in ibrutinib-treated mantle cell lymphoma
    Fuhr, Viktoria
    Heidenreich, Shanice
    Srivastava, Mugdha
    Riedel, Angela
    Duell, Johannes
    Gerhard-Hartmann, Elena
    Rosenwald, Andreas
    Rauert-Wunderlich, Hilka
    CELL DEATH DISCOVERY, 2022, 8 (01)
  • [28] Ibrutinib to Allogenic Stem Cell Transplant in a Case of Refractory Mantle Cell Lymphoma
    Ahmed, Rayaz
    Kapoor, Jyotsna
    Agrawal, Narendra
    Verma, Priyanka
    Bhurani, Dinesh
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2018, 34 (02) : 360 - 361
  • [29] Ibrutinib to Allogenic Stem Cell Transplant in a Case of Refractory Mantle Cell Lymphoma
    Rayaz Ahmed
    Jyotsna Kapoor
    Narendra Agrawal
    Priyanka Verma
    Dinesh Bhurani
    Indian Journal of Hematology and Blood Transfusion, 2018, 34 : 360 - 361
  • [30] EFFECTIVENESS AND SAFETY OF IBRUTINIB IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA TREATED IN ITALY ACCORDING TO THE IBRUTINIB NAMED PATIENT PROGRAM: THE REAL LIFE RESULTS
    Morigi, A.
    Sottotetti, F.
    Gotti, M.
    Spina, M.
    Volpetti, S.
    Ferrero, S.
    Spina, F.
    Pisani, F.
    Merli, M.
    Visco, C.
    Paolini, R.
    Zilioli, V. R.
    Baldini, L.
    Di Renzo, N.
    Tosi, P.
    Cascavilla, N.
    Molica, S.
    Ilariucci, F.
    Rigolin, G. M.
    D'Alo, F.
    Vanazzi, A.
    Santambrogio, E.
    Marasca, R.
    Mastrullo, L.
    Castellino, C.
    Desabbata, G.
    Scortechini, I.
    Trentin, L.
    Morello, L.
    Argnani, L.
    Zinzani, P. L.
    HAEMATOLOGICA, 2017, 102 : 49 - 50
12345